Serveur d'exploration sur l'Indium - Analysis (France)

Index « Auteurs » - entrée « Caroline Rousseau »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

List of bibliographic references

Number of relevant bibliographic references: 3

.
Ident.Authors (with country if any)Title
000023 (2012) Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-BodéréPhase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000094 (2006) Françoise Kraeber-Bodéré (France) ; Caroline Rousseau ; Caroline Bodet-Milin ; Ludovic Ferrer ; Alain Faivre-Chauvet ; Loïc Campion ; Jean-Philippe Vuillez ; Anne Devillers ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques BarbetTargeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
000129 (2003) Françoise Kraeber-Bodéré (France) ; Alain Faivre-Chauvet ; Ludovic Ferrer ; Jean-Philippe Vuillez ; Pierre-Yves Brard ; Caroline Rousseau ; Isabelle Resche ; Anne Devillers ; Sophie Laffont ; Manuel Bardiès ; Ken Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques BarbetPharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Adult
3Aged
3Humans
3Male
3Middle Aged
3Radioimmunotherapy (methods)
2Antibodies, Bispecific (adverse effects)
2Female
2Neoplasm Metastasis
2Radioimmunotherapy (adverse effects)
2Thyroid Neoplasms (radiotherapy)
2Treatment Outcome
1Aged, 80 and over
1Animals
1Antibodies, Bispecific (administration & dosage)
1Antibodies, Bispecific (chemistry)
1Antibodies, Bispecific (pharmacokinetics)
1Antibodies, Bispecific (therapeutic use)
1Antibodies, Monoclonal (administration & dosage)
1Antibodies, Monoclonal (adverse effects)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Bone Marrow (pathology)
1Carcinoembryonic Antigen (chemistry)
1Carcinoembryonic Antigen (immunology)
1Disease Progression
1Dose Fractionation
1Haptens (administration & dosage)
1Haptens (adverse effects)
1Haptens (chemistry)
1Iodine Radioisotopes (administration & dosage)
1Iodine Radioisotopes (adverse effects)
1Iodine Radioisotopes (therapeutic use)
1Mice
1Neoplasms (therapy)
1Pentetic Acid (immunology)
1Quality Control
1Radiation Injuries (diagnosis)
1Radiation Injuries (etiology)
1Radiometry
1Radiopharmaceuticals (administration & dosage)
1Radiopharmaceuticals (adverse effects)
1Radiotherapy Dosage
1Risk Assessment (methods)
1Survival Analysis
1Thyroid Neoplasms (diagnosis)
1Thyroid Neoplasms (metabolism)
1Thyroid Neoplasms (pathology)
1Time Factors
1Tissue Distribution
1Tumor Markers, Biological (metabolism)
1Young Adult

Affichage en shell (Unix/Dilib)

IndexSelect -h IndiumV2/Data/France/Analysis/Author.i -k "Caroline Rousseau" 
IndexSelect -h IndiumV2/Data/France/Analysis/Author.i  \
                -Sk "Caroline Rousseau" \
         | HfdSelect -Kh IndiumV2/Data/France/Analysis/biblio.hfd 

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Tue May 20 08:20:52 2014